Physician profile
Daniel J Emerson
NPI 1962477562
$8,291.12
in general payments reported to CMS, 2019-2025
8 companies · $1,207 in 2025
The $1,207 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,442 · 2021: $94.01 · 2022: $2,373 · 2023: $846 · 2024: $1,329 · 2025: $1,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,265 · Food and Beverage: $1,118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,264.87 |
| Food and Beverage | $1,117.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,540.18 | 2021-2025 | Comprehensive Shoulder System, Oxford, Comprehensive |
| Arthrex, INC. | $1,931.00 | 2019-2025 | |
| Exactech, INC. | $1,296.76 | 2022 | |
| Medacta USA, INC. | $781.71 | 2023 | Amistem |
| Alpha Orthopedic Systems | $534.86 | 2019 | |
| Depuy Synthes Sales INC. | $142.40 | 2022-2025 | Fms Duo, Vapr, Fms |
| Stryker Corporation | $47.74 | 2023 | Champion Slingshot, Arthrotunneler Tunnelpro System |
| Janssen Pharmaceuticals, INC | $16.47 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Emerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.